Perez-Hoyos S - Search Results

1

Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia.

Jarrin I, Pantazis N, Gill MJ, Geskus R, Perez-Hoyos S, Meyer L, Prins M, Touloumi G, Johnson A, Hamouda O, de Olalla PG, Porter K, del Amo J; CASCADE Collaboration in EuroCoord. Jarrin I, et al. Clin Infect Dis. 2012 Jan 1;54(1):111-8. doi: 10.1093/cid/cir814. Epub 2011 Nov 21. Clin Infect Dis. 2012. PMID: 22109944

2

Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women.

Jarrin I, Geskus R, Bhaskaran K, Prins M, Perez-Hoyos S, Muga R, Hernández-Aguado I, Meyer L, Porter K, del Amo J; CASCADE Collaboration. Jarrin I, et al. Am J Epidemiol. 2008 Sep 1;168(5):532-40. doi: 10.1093/aje/kwn179. Epub 2008 Jul 28. Am J Epidemiol. 2008. PMID: 18663213

3

Educational level and HIV disease progression before and after the introduction of HAART: a cohort study in 989 HIV seroconverters in Spain.

Monge S, Jarrín I, Pérez-Hoyos S, Ferreros I, García-Olalla P, Muga R, Del Romero J, Belda J, Castilla J, Bolúmar F, Del Amo J; GEMES. Monge S, et al. Sex Transm Infect. 2011 Dec;87(7):571-6. doi: 10.1136/sextrans-2011-050125. Epub 2011 Oct 3. Sex Transm Infect. 2011. PMID: 21968461

4

Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts.

Touloumi G, Pantazis N, Pillay D, Paraskevis D, Chaix ML, Bucher HC, Kücherer C, Zangerle R, Kran AM, Porter K; CASCADE collaboration in EuroCoord. Touloumi G, et al. Clin Infect Dis. 2013 Mar;56(6):888-97. doi: 10.1093/cid/cis1000. Epub 2012 Dec 7. Clin Infect Dis. 2013. PMID: 23223594

5

Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category.

Pérez-Hoyos S, del Amo J, Muga R, del Romero J, García de Olalla P, Guerrero R, Hernàndez-Aguado I; GEMES (Spanish Multicenter Study Group of Seroconverters). Pérez-Hoyos S, et al. AIDS. 2003 Feb 14;17(3):353-9. doi: 10.1097/00002030-200302140-00009. AIDS. 2003. PMID: 12556689

6

Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.

García de la Hera M, Ferreros I, del Amo J, García de Olalla P, Pérez Hoyos S, Muga R, del Romero J, Guerrero R, Hernández-Aguado I; GEMES. García de la Hera M, et al. J Epidemiol Community Health. 2004 Nov;58(11):944-50. doi: 10.1136/jech.2003.017475. J Epidemiol Community Health. 2004. PMID: 15483312 Free PMC article.

7

Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on.

Pérez-Hoyos S, Ferreros I, del Amo J, Muga R, del Romero J, de Olalla PG, Hernández-Aguado I. Pérez-Hoyos S, et al. AIDS. 2006 Jan 9;20(2):289-91. doi: 10.1097/01.aids.0000202651.41397.db. AIDS. 2006. PMID: 16511426

8

Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.

Muga R, Ferreros I, Langohr K, de Olalla PG, Del Romero J, Quintana M, Alastrue I, Belda J, Tor J, Pérez-Hoyos S, Del Amo J; Spanish Multicenter Study Group of Seroconverters (GEMES). Muga R, et al. AIDS. 2007 Nov 30;21(18):2521-7. doi: 10.1097/QAD.0b013e3282f1c933. AIDS. 2007. PMID: 18025889

9

Response to combination antiretroviral therapy: variation by age.

Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group; Sabin CA, Smith CJ, d'Arminio Monforte A, Battegay M, Gabiano C, Galli L, Geelen S, Gibb D, Guiguet M, Judd A, Leport C, Dabis F, Pantazis N, Porter K, Raffi F, Thorne C, Torti C, Walker S, Warszawski J, Wintergerst U, Chene G, Lundgren J. Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group, et al. AIDS. 2008 Jul 31;22(12):1463-73. doi: 10.1097/QAD.0b013e3282f88d02. AIDS. 2008. PMID: 18614870

10

Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice.

Touloumi G, Pantazis N, Stirnadel HA, Walker AS, Boufassa F, Vanhems P, Porter K; CASCADE Collaboration. Touloumi G, et al. J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):492-8. doi: 10.1097/QAI.0b013e318186ead2. J Acquir Immune Defic Syndr. 2008. PMID: 18989233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page